Pharmaceutical Design and In Vitro Evaluation of a Dual Layer Valproic Acid Tablet for Enhanced Therapeutic Efficacy and Controlled Drug Release

Authors

  • Shreya
  • Abhay Thakur
  • Sahil Thakur
  • Anjana devi

Keywords:

Valproic acid, Dual-layer tablet, Controlled release, Biopharmaceutical evaluation, Patient compliance

Abstract

Valproic acid is a widely prescribed antiepileptic drug known for its broad-spectrum efficacy, yet its conventional formulations are limited by a short half-life, fluctuating plasma levels, and frequent dosing requirements, all of which compromise therapeutic efficacy and patient compliance. To overcome these challenges, this study focuses on the formulation and evaluation of a dual-layer tablet comprising an immediate-release (IR) layer and a sustained-release (SR) layer. The IR layer facilitates rapid onset of action, while the SR layer ensures prolonged drug release, reducing dosing frequency and enhancing plasma concentration stability. Preformulation studies assessed drug-excipient compatibility using FTIR and DSC, while the final bi-layer tablets were evaluated for physicochemical properties, in vitro dissolution profiles, and comparative performance against marketed formulations. Results demonstrated that the optimized bi-layer formulation successfully achieved biphasic drug release, improved dissolution performance, and offered a promising approach for long-term valproic acid therapy. The formulation aligns with current pharmaceutical trends toward patient-centric, controlled-release dosage forms and represents a significant step forward in improving antiepileptic drug delivery.

Downloads

Download data is not yet available.

References

Liu, D., Yan, H., Kong, Y., You, Y., Li, Y., Wang, L., ... & Wang, J. (2018). Preparation of colon-targeted acetylharpagide tablets and its release properties in vivo and in vitro. Frontiers in Pharmacology, 9, 832.

Pisal, S., Zainnuddin, R., Nalawade, P., Mahadik, K., & Kadam, S. (2004). Molecular properties of ciprofloxacin-Indion 234 complexes. AAPS PharmSciTech, 5, 84-91.

Costa, P., & Lobo, J. M. S. (2001). Modeling and comparison of dissolution profiles. European journal of pharmaceutical sciences, 13(2), 123-133.

Fujii, A., Yasui-Furukori, N., Nakagami, T., Niioka, T., Saito, M., Sato, Y., & Kaneko, S. (2009). Comparative in vivo bioequivalence and in vitro dissolution of two valproic acid sustained-release formulations. Drug design, development and therapy, 139-144.

Abutaleb, S., Mallah, E., Abu-Qatouseh, L., Abu-Awwad, A., Mansoor, K., Khallad, S., ... & Arafat, T. (2025). Valproic acid levels in neurodevelopmental disorders: correlation with CYP and SULT genes using LC-MS/MS. BMC neurology, 25(1), 1-9.

Yuan, X., Marcano, D. C., Shin, C. S., Hua, X., Isenhart, L. C., Pflugfelder, S. C., & Acharya, G. (2015). Ocular drug delivery nanowafer with enhanced therapeutic efficacy. ACS nano, 9(2), 1749-1758.

Shiyani, B., Gattani, S., & Surana, S. (2008). Formulation and evaluation of bi-layer tablet of metoclopramide hydrochloride and ibuprofen. Aaps Pharmscitech, 9(3), 818-827.

Badria, F. A., Fayed, H. A., Ibraheem, A. K., State, A. F., & Mazyed, E. A. (2020). Formulation of sodium valproate nanospanlastics as a promising approach for drug repurposing in the treatment of androgenic alopecia. Pharmaceutics, 12(9), 866.

Singh, S., Singh, A., Bhandari, A., Sharma, S. K., Singh, S., & Kumar, D. (2020). Formulation and Evaluation of Ointment of Valproic Acid. Asian Journal of Pharmaceutical Research and Development, 8(3), 246-251.

Romoli, M., Mazzocchetti, P., D'Alonzo, R., Siliquini, S., Rinaldi, V. E., Verrotti, A., ... & Costa, C. (2019). Valproic acid and epilepsy: from molecular mechanisms to clinical evidences. Current neuropharmacology, 17(10), 926-946.

Singh, B., Saini, G., Vyas, M., Verma, S., & Thakur, S. (2019). Optimized chronomodulated dual release bilayer tablets of fexofenadine and montelukast: quality by design, development, and in vitro evaluation. Future Journal of Pharmaceutical Sciences, 5, 1-20.

Dhavala, S. S. (2014). Design, Fabrication And Evaluation Of A Novel Microfluidic Based In Vitro Cell Migration Assay.

Patel, K., Doddapaneni, R., Patki, M., Sekar, V., Bagde, A., & Singh, M. (2019). Erlotinib-valproic acid liquisolid formulation: evaluating oral bioavailability and cytotoxicity in erlotinib-resistant non-small cell lung cancer cells. AAPS PharmSciTech, 20, 1-11.

Choudhury, A. R., Karanam, M., Joshi, M., Verma, I., Gulati, A., Budhwar, C., ... & Dev, S. (2021). Pharmaceutical cocrystallization: polymorphs, salts and cocrystals. Acta Cryst, 77, C878.

Jaiswal, A., Venkatachalam, S., De, A., Namdev, B., Ramaswamy, R., & Natarajan, J. (2021). Preparation, Characterization and Optimization of Repurposed Valproic Acid Loaded Carboxymethyl Chitosan Nanoparticles by Box–Behnken Design for Alzheimer Management. Indian J. Pharm. Educ. Res, 55, 75-86.

Dutta, S., & Reed, R. C. (2007). Distinct absorption characteristics of oral formulations of valproic acid/divalproex available in the United States. Epilepsy research, 73(3), 275-283.

Gugler, R., & von Unruh, G. E. (1980). Clinical pharmacokinetics of valproic acid. Clinical pharmacokinetics, 5, 67-83.

Mendes, G. D., Lotufo, C. C., Bosio-Guimaraes, R. A., de Castro, H. A., Babadopulos, T., Freitas, A. R. R., ... & De Nucci, G. (2022). Comparative bioavailability study with two sodium valproate tablet formulations administered under fasting conditions in healthy subjects. International Journal of Clinical Pharmacology and Therapeutics, 60(5), 232.

Rogawski, M. A., & Wenk, G. L. (2003). The neuropharmacological basis for the use of memantine in the treatment of Alzheimer's disease. CNS drug reviews, 9(3), 275-308.

Dutta, S., Reed, R. C., & Cavanaugh, J. H. (2004). Absolute bioavailability and absorption characteristics of divalproex sodium extended‐release tablets in healthy volunteers. The Journal of Clinical Pharmacology, 44(7), 737-742.

Avrahami, M., Liwinski, T., Eckstein, Z., Peskin, M., Perlman, P., Sarlon, J., ... & Weizman, A. (2024). Predictors of valproic acid steady-state serum levels in adult and pediatric psychiatric inpatients: a comparative analysis. Psychopharmacology, 241(9), 1883-1894.

Haroun, A., Masoud, R. A., & Osman, A. H. (2024). Preparation and Characterization of Immobilized Valproic acid onto Tetraethyl Orthosilicate. Journal of Sustainable Materials Processing and Management, 4(2), 15-23.

Hegde, N., Juvale, K., Puri, S., Chavan, A., & Shah, S. (2024). Box-Behnken design based optimization of polyvinylpyrrolidone stabilized valproic acid nanoemulsion and evaluation of its anticancer potential. Colloid and Polymer Science, 302(10), 1523-1539.

Salimi, A., Jafarian, S., Salimi, A., & Mohammad Soleymani, S. (2024). Formulation and Evaluation of Valproic Acid Microemulsions for Enhanced Transfollicular Delivery in Guinea Pig Skin. Journal of Cosmetic Dermatology, e16685.

Kaewpradit, S., Yusakul, G., Rojsitthisak, P., & Jantarat, C. (2024). A simple and rapid HPLC-UV method for the determination of valproic acid in human plasma using microwave-assisted derivatization with phenylhydrazine hydrochloride. Heliyon, 10(6).

Schiavo, A., Fagiolino, P., Vázquez, M., Tróconiz, I., & Ibarra, M. (2024). Model-Based Bioequivalence Analysis to Assess and Predict the Relative Bioavailability of Valproic Acid Formulations. European Journal of Drug Metabolism and Pharmacokinetics, 49(4), 507-516.

Gaidău, C., Râpă, M., Stefan, L. M., Matei, E., Berbecaru, A. C., Predescu, C., & Mititelu-Tartau, L. (2023). Conversion of animal-derived protein by-products into a new dual-layer nanofiber biomaterial by electrospinning process. Fibers, 11(10), 87.

Zhang, C., Shao, H., Han, Z., Liu, B., Feng, J., Zhang, J., ... & Wu, S. (2023). Development and in Vitro− in Vivo Correlation Evaluation of IMM-H014 Extended–Release Tablets for the Treatment of Fatty Liver.

Cetin, A., Özbek, O., & Erol, A. (2023). Development of a potentiometric sensor for the determination of carbamazepine and its application in pharmaceutical formulations. Journal of Chemical Technology & Biotechnology, 98(4), 890-897.

Lee, Y. J., & Kim, J. E. (2022). In Vitro–In Vivo Correlation of Tianeptine Sodium Sustained-Release Dual-Layer Tablets. Molecules, 27(9), 2828.

Parys, W., & Pyka-Pająk, A. (2022). Use of TLC-densitometric method for determination of valproic acid in capsules. Molecules, 27(3), 752.

Vohra, M., Amir, M., Sharma, A., & Wadhwa, S. (2022). Journal of Pharmaceutical Technology Research and Management.

Zang, Y. N., Guo, W., Dong, F., Li, A. N., de Leon, J., & Ruan, C. J. (2022). Published population pharmacokinetic models of valproic acid in adult patients: A systematic review and external validation in a Chinese sample of inpatients with bipolar disorder. Expert Review of Clinical Pharmacology, 15(5), 621-635.

Yuwanda, A., Surini, S., Harahap, Y., & Jufri, M. (2022). Study of valproic acid liposomes for delivery into the brain through an intranasal route. Heliyon, 8(3).

SA’ADON, S. B. (2022). PREPARATION, CHARACTERIZATION AND PHARMACOKINETIC RELEASE OF DICLOFENAC SODIUM-DUAL LAYER POLYVINYL ALCOHOL PATCH FOR TRANSDERMAL DELIVERY (Doctoral dissertation, Universiti Teknologi Malaysia).

Abd Kelkawi, A. H., Hashemzadeh, H., Pashandi, Z., Tiraihi, T., & Naderi-Manesh, H. (2022). Differentiation of PC12 cell line into neuron by Valproic acid encapsulated in the stabilized core-shell liposome-chitosan Nano carriers. International Journal of Biological Macromolecules, 210, 252-260.

Khajir, S., Shayanfar, A., Monajjemzadeh, F., & Jouyban, A. (2021). Crystal engineering of valproic acid and carbamazepine to improve hygroscopicity and dissolution profile. Drug Development and Industrial Pharmacy, 47(10), 1674-1679.

Gu, X., Zhu, M., Sheng, C., Yu, S., Peng, Q., Ma, M., ... & Zhou, B. (2021). Population pharmacokinetics of unbound valproic acid in pediatric epilepsy patients in China: A protein binding model. European Journal of Clinical Pharmacology, 77, 999-1009.

Vicatos, A. I., & Caira, M. R. (2021). Cyclodextrin complexes of the anticonvulsant agent valproic acid. CrystEngComm, 23(37), 6582-6590.

Karlov, V. A., Kozhokaru, A. B., Vlasov, P. N., Pushkar, T. N., & Orlova, A. S. (2021). Dynamics of Epileptiform Activity and the Efficacy and Tolerance of Valproic Acid Formulations in Adolescents and Adults with Newly Diagnosed Epilepsy. Neuroscience and Behavioral Physiology, 51, 289-297.

Khadse, S. A., & Mohite, M. T. (2021). Formulation and evaluation of transdermal patch of stiripentol for treatment of seizures: https://doi. org/10.54037/WJPS. 2021.91005. World Journal of Pharmaceutical Sciences, 24-30.

Haugse, R. (2020). Molecular mechanisms of sonoporation in cancer therapy: Optimization of sonoporation parameters and investigations of intracellular signalling.

Huang, X., Gao, S., Ma, Y., Lu, X., Jia, Z., & Hou, Y. (2020). The optimal monoenergetic spectral image level of coronary computed tomography (CT) angiography on a dual-layer spectral detector CT with half-dose contrast media. Quantitative imaging in medicine and surgery, 10(3), 592.

Downloads

Published

2025-06-04

How to Cite

1.
Shreya S, Thakur A, Thakur S, devi A. Pharmaceutical Design and In Vitro Evaluation of a Dual Layer Valproic Acid Tablet for Enhanced Therapeutic Efficacy and Controlled Drug Release. J Neonatal Surg [Internet]. 2025Jun.4 [cited 2025Jun.20];14(31S):22-37. Available from: https://jneonatalsurg.com/index.php/jns/article/view/7064

Issue

Vol. 14 No. 31S (2025): Journal of Neonatal Surgery

Section

Original Article

License

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

You are free to:

  • Adapt — remix, transform, and build upon the material for any purpose, even commercially.

Terms:

  • Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
  • No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.